# SCOT Registry: Small Cell Lung Cancer Treatment and Outcome

> **NCT00997061** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 500 (actual)

## Conditions studied

- Lung Cancer, Small Cell

## Interventions

- **DRUG:** HYCAMTIN

## Key facts

- **NCT ID:** NCT00997061
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2014-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00997061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00997061, "SCOT Registry: Small Cell Lung Cancer Treatment and Outcome". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00997061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*